search for books and compare prices
Vibeke Strand has written 4 work(s)
Search for other authors with the same name
displaying 1 to 4 |
at end
show results in order: alphabetically | oldest to newest | newest to oldest
Miscellaneous:
9781444315851 | B M J Books, July 28, 2009, cover price $236.95
Product Description: Compiled by Cochrane collaborators and members of OMERACT (Outcome Measures in Rheumatology), Evidence-based Rheumatology is an essential resource for evidence-based medicine as applied to the musculoskeletal disorders. The introductory section covers the principles of evidence-based medicine in rheumatology, followed by clinical chapters covering all the major disorders...read more
Hardcover:
9780727914460 | Hardcover with CD edition (B M J Books, June 1, 2004), cover price $300.00 | About this edition: Compiled by Cochrane collaborators and members of OMERACT (Outcome Measures in Rheumatology), Evidence-based Rheumatology is an essential resource for evidence-based medicine as applied to the musculoskeletal disorders.
Product Description: Recognizing the explosive growth in information on intravenous immunoglobulins (IVIGs), this exhaustive single-source volume surveys all available literature on the employment of IVIG preparations in clinical practice from pharmacoeconomics and pharmacokinetics to prophylaxis and management of infectious and autoimmune diseases...read more (view table of contents, read Amazon.com's description)
Hardcover:
9780824798819 | CRC Pr I Llc, August 1, 1997, cover price $188.95 | About this edition: Recognizing the explosive growth in information on intravenous immunoglobulins (IVIGs), this exhaustive single-source volume surveys all available literature on the employment of IVIG preparations in clinical practice from pharmacoeconomics and pharmacokinetics to prophylaxis and management of infectious and autoimmune diseases.
Hardcover:
9780824797485 | CRC Pr I Llc, January 1, 1997, cover price $243.00 | About this edition: Provides a detailed survey of therapies for autoimmune diseases, exploring the rationale for their use and clinical data regarding their potential benefit.
displaying 1 to 4 |
at end